GlassScriptPhysician profile
Kassandre S Balocca
NPI 1205258027
$1,289.49
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $257 · 2023: $290 · 2024: $321 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $369.35 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $235.15 | 2021-2025 | Verquvo |
| Pfizer INC. | $186.84 | 2021-2024 | |
| Amgen INC. | $87.86 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $82.18 | 2022-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $54.05 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $53.36 | 2023-2024 | Watchman Flx, Watchman, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.81 | 2021-2024 | Lifevest |
| Abbott Laboratories | $41.98 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Kowa Pharmaceuticals America, INC. | $24.46 | 2021 | |
| Cvrx, INC. | $22.00 | 2024 | Barostim Neo System |
| Arbor Pharmaceuticals, INC. | $18.74 | 2021 | |
| Esperion Therapeutics, INC. | $17.81 | 2024 | Nexletol |
| Surmodics, INC. | $15.86 | 2023 | Pounce Thrombectomy, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $14.15 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kassandre Balocca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.